BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7088754)

  • 1. The penetration of metronidazole into synovial fluid.
    Sattar MA; Sankey MG; Cawley MI; Kaye CM; Holt JE
    Postgrad Med J; 1982 Jan; 58(675):20-4. PubMed ID: 7088754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The penetration of trimethoprim and sulphamethoxazole into synovial fluid.
    Sattar MA; Cawley MI; Holt JE; Sankey MG; Kaye CM
    J Antimicrob Chemother; 1983 Sep; 12(3):229-33. PubMed ID: 6605336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteroides fragilis arthritis in a sickle cell-thalassaemia patient.
    Konstantopoulos K; Avlami A; Demarongona K; Sideris G; Rekoumi L; Stefanou J; Voskaridou E; Loukopoulos D
    Scand J Infect Dis; 1994; 26(4):495-7. PubMed ID: 7984987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of some antibiotics in synovial fluid after oral administration, with special reference to antistaphylococcal activity.
    Sattar MA; Barrett SP; Cawley MI
    Ann Rheum Dis; 1983 Feb; 42(1):67-74. PubMed ID: 6830326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronidazole hydrochloride (Flagyl I.V.).
    Med Lett Drugs Ther; 1981 Feb; 23(4):13-4. PubMed ID: 7464682
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetics/pharmacodinamic (PK/PD) evaluation of a short course of oral administration of metronidazole for the management of infections caused by Bacteroides fragilis].
    Morales-León F; von Plessing-Rossel C; Villa-Zapata L; Fernández-Rocca P; Sanhueza-Sanhueza C; Bello-Toledo H; Mella-Montecinos S
    Rev Chilena Infectol; 2015 Apr; 32(2):135-41. PubMed ID: 26065445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole treatment of Bacteroides fragilis infections.
    Melo JC; Raff MJ; Wunderlich HF; Chun CH; Summersgill JT; Varghese R
    Am J Med Sci; 1980; 280(3):143-9. PubMed ID: 7457495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Septic polyarthritis due to Bacteroides fragilis in a patient with rheumatoid arthritis. A case report.
    Schorn D; Pretorius JA
    S Afr Med J; 1982 Aug; 62(7):213-4. PubMed ID: 7101073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscess.
    Warner JF; Perkins RL; Cordero L
    Arch Intern Med; 1979 Feb; 139(2):167-9. PubMed ID: 434970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyogenic arthritis due to bacteroides complicating rheumatoid arthritis.
    Dodd MJ; Griffiths ID; Freeman R
    Ann Rheum Dis; 1982 Jun; 41(3):248-9. PubMed ID: 6124215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metronidazole resistant Bacteroides fragilis infection of a prosthetic hip joint.
    Hickey MM; Davies UM; Dave J; Vogler M; Wall RA
    J Infect; 1990 Mar; 20(2):129-33. PubMed ID: 2319145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyomyositis and septic arthritis due to Bacteroides fragilis in an immunocompetent patient.
    Calvo-Alén J; Pinillos V; del Val N; Rodríguez Valverde V
    Clin Infect Dis; 1995 Nov; 21(5):1344. PubMed ID: 8589179
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacteroides fragilis endocarditis, bacteremia and other infections treated with oral or intravenous metronidazole.
    Galgiani JN; Busch DF; Brass C; Rumans LW; Mangels JI; Stevens DA
    Am J Med; 1978 Aug; 65(2):284-9. PubMed ID: 686012
    [No Abstract]   [Full Text] [Related]  

  • 14. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amikacin penetration into synovial fluid during treatment of septic arthritis.
    Honda DH; Adams HG; Barriere SL
    Drug Intell Clin Pharm; 1981 Apr; 15(4):284-6. PubMed ID: 7023898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
    Shimada K; Inamatsu T; Sato K
    Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and synovial fluid steady-state concentrations of trimethoprim and sulfadiazine in horses with experimentally induced infectious arthritis.
    Bertone AL; Jones RL; McIlwraith CW
    Am J Vet Res; 1988 Oct; 49(10):1681-7. PubMed ID: 3189982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral antibiotic therapy for skeletal infections of children. I. Antibiotic concentrations in suppurative synovial fluid.
    Nelson JD; Howard JB; Shelton S
    J Pediatr; 1978 Jan; 92(1):131-4. PubMed ID: 619055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy for septic arthritis.
    Ho G; Su EY
    JAMA; 1982 Feb; 247(6):797-800. PubMed ID: 7057556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.